Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1002830 | 1.00 | GABRA1 (0.41) | GABRA1GABRG2GABRB3LMNAGABRB2 | |
| SCHEMBL27608902 | 0.98 | GABRA1 (0.40) | GABRA1GABRG2GABRB3LMNAGABRB2 | |
| SCHEMBL5589413 | 0.98 | GABRA1 (0.40) | GABRA1GABRG2GABRB3LMNAGABRB2 | |
| Hydrochloric Acid SCHEMBL7171618 | 0.97 | GABRA1 (0.39) | GABRA1GABRG2GABRB3LMNAGABRB2 | |
| Hydrochloric Acid SCHEMBL6915966 | 0.97 | GABRA1 (0.39) | GABRA1GABRG2GABRB3LMNAGABRB2 | |
| Hydrochloric Acid SCHEMBL1685885 | 0.97 | GABRA1 (0.39) | GABRA1GABRG2GABRB3LMNAGABRB2 | |
| Hydrochloric Acid SCHEMBL1575632 | 0.97 | GABRA1 (0.39) | GABRA1GABRG2GABRB3LMNAGABRB2 | |
| Hydrochloric Acid SCHEMBL7176112 | 0.97 | GABRA1 (0.39) | GABRA1GABRG2GABRB3LMNAGABRB2 | |
| Hydrochloric Acid SCHEMBL6909108 | 0.97 | GABRA1 (0.39) | GABRA1GABRG2GABRB3LMNAGABRB2 | |
| Hydrochloric Acid SCHEMBL1575753 | 0.97 | GABRA1 (0.39) | GABRA1GABRG2GABRB3LMNAGABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3135697-B1 | CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST THEREOF | CHINA PETROLEUM & CHEM CORP (CN) | 2019-08-14 | — | — | EP | claimed |
| US-10208145-B2 | Catalyst component for olefin polymerization, and catalyst containing the same | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2019-02-19 | — | — | US | claimed |
| US-20170073441-A1 | Catalyst Component For Olefin Polymerization, and Catalyst Containing the Same | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2017-03-16 | — | — | US | claimed |
| EP-3135697-A1 | CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST THEREOF | China Petroleum & Chemical Corporation (CN) | 2017-03-01 | — | — | EP | claimed |
| EP-3184172-B1 | HYDROSILYLATION IRON CATALYST | UNIV KYUSHU NAT UNIV CORP (JP) | 2024-09-04 | — | — | EP | disclosed |
| US-20230192744-A1 | Transition Metal-Complex Catalysts Having Appended Group 13 Lewis Acids and Related Polymerization Methods | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-06-22 | — | — | US | disclosed |
| US-20230192744-A1 | Transition Metal-Complex Catalysts Having Appended Group 13 Lewis Acids and Related Polymerization Methods | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2023112847-A1 | ORGANOSILOXANE-BASED HYDROGEN STORAGE COMPOSITION | 国立大学法人東京大学 | 2023-06-22 | — | — | WO | disclosed |
| US-20230117728-A1 | LIGHT AS CATALYTIC SWITCH: METAL-ORGANIC INSERTION/LIGHT INITIATED RADICAL (MILRad) POLYMERIZATION | UNIVERSITY OF HOUSTON SYSTEM (US) | 2023-04-20 | — | — | US | disclosed |
| US-20220008347-A1 | Self-Assembled Microcapsules With Stimuli-Responsive Organic Ligands | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-01-13 | — | — | US | disclosed |
| WO-2021222018-A1 | TRANSITION METAL-COMPLEX CATALYSTS HAVING APPENDED GROUP 13 LEWIS ACIDS AND RELATED POLYMERIZATION METHODS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-11-04 | — | — | WO | disclosed |
| EP-2797862-B1 | OLEFIN OLIGOMERIZATION METHODS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2021-04-07 | — | — | EP | disclosed |
| US-20040127382-A1 | Use of transition metal complexes with nitrogen-containing polydentate ligands as a bleaching catalyst and bleaching agent composition | DEGUSSA AG (DE) | 2004-07-01 | — | — | US | disclosed |
| US-20040044149-A1 | Cr complexes and their use for the polymerization of alpha-olefins | SOLVAY POLYOLEFINS EUROPE-BELGIUM (BE) | 2004-03-04 | — | — | US | disclosed |
| EP-1320537-A1 | CR COMPLEXES AND THEIR USE FOR THE POLYMERIZATION OF ALPHA-OLEFINS | Université de Liège (BE) | 2003-06-25 | — | — | EP | disclosed |
| WO-2002036643-A1 | METHOD FOR POLYMERISING ALPHA-OLEFINS | SOLVAY POLYOLEFINS EUROPE - BELGIUM (Société Anonyme) (BE) | 2002-05-10 | — | — | WO | disclosed |
| EP-1201683-A1 | Process for the polymerisation of alpha-olefins | SOLVAY POLYOLEFINS EUROPE - BELGIUM (Société Anonyme) (BE) | 2002-05-02 | — | — | EP | disclosed |
| WO-2002022628-A1 | CR COMPLEXES AND THEIR USE FOR THE POLYMERIZATION OF ALPHA-OLEFINS | UNIVERSITE DE LIEGE (BE) | 2002-03-21 | — | — | WO | disclosed |
| EP-1188762-A1 | Chromium complexes and their use for the polymerization of alpha-olefins | Solvay Polyolefins Europe-Belgium (Société Anonyme) (BE) | 2002-03-20 | — | — | EP | disclosed |
| EP-1059313-A1 | Transition metal catalyst component for polymerization, aromatic vinyl compound-olefin copolymer and process for its production by means of the catalyst component | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2000-12-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192744-A1 | Transition Metal-Complex Catalysts Having Appended Group 13 Lewis Acids and Related Polymerization Methods | LIG3, LGMN, PARG | GABRA1 2875/4885GABRG2 3201/4885GABRB3 3196/4885 |
| US-20220008347-A1 | Self-Assembled Microcapsules With Stimuli-Responsive Organic Ligands | MLEC, MSN, EPHA2 | GABRA1 3459/4885GABRG2 4036/4885GABRB3 4329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.